Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

  • There is currently no data for CRL

Director/PDMR Shareholding

20 Mar 2025 11:36

RNS Number : 5216B
Creightons PLC
20 March 2025
Β 

Creightons plc

Director/PDMR Shareholding

Β 

Notification of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")

Β 

Creightons plc ("Creightons", "the Company" or "the Group"),Β the British-based beauty and well-being brand owner and manufacturer, announces that Paul Forster, Non-Executive Director, transferred 200,000 ordinary shares of 1 pence each in the Company ("Ordinary Share") to his wife, Clare Forster, on 19 March 2025. Mr Forster's beneficial holding remains at 951,318, representing 1.4% of the issued share capital.

Β 

The Notification of Dealing is set out below.

Β 

The following transaction has been notified to the Company pursuant to Article 19.1(a) of the UK Market Abuse Regulation ("MAR"). This notification is issued in accordance with Article 19.3 of MAR.

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Paul Forster

2

Reason for the notification

a)

Position/Status:

Β 

PDMR (Non-Executive Director)

b)

Initial Notification/Amendment:

Β 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

a)

Name:

Creightons plc

b)

LEI:

213800WROWAJUBGSAJ57

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument:

Β 

Ordinary Shares of 1 pence each

Β 

b)

Identification code:

ISIN: GB0002341666

Β 

b)

Nature of the transaction:

Β 

Transfer of Ordinary Shares to a spouse

c)

Price(s) and volume(s):

Β 

Price

Volume

Nil

200,000

Β 

d)

Aggregated volume:

Price:

Single Transaction

e)

Date of the Transaction:

2025-03-19

f)

Place of the Transaction:

Outside a trading venue

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Clare Forster

2

Reason for the notification

a)

Position/Status:

Β 

PCA of Paul Forster, PDMR (Non-Executive Director)

b)

Initial Notification/Amendment:

Β 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

a)

Name:

Creightons plc

b)

LEI:

213800WROWAJUBGSAJ57

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument:

Β 

Ordinary Shares of 1 pence each

Β 

b)

Identification code:

ISIN: GB0002341666

Β 

b)

Nature of the transaction:

Β 

Transfer of Ordinary Shares from a spouse

c)

Price(s) and volume(s):

Β 

Price

Volume

Nil

200,000

Β 

d)

Aggregated volume:

Price:

Single Transaction

e)

Date of the Transaction:

2025-03-19

f)

Place of the Transaction:

Outside a trading venue

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHJMMBTMTJTBIA
Date   Source Headline
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding
29th Oct 20215:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.